EN
抗体药类似物
Research Grade Lumiliximab
All
TD-HY541016_1.jpg
  • CatalogTD-HY541016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsIDEC-152,P5E8,CAS:357613-86-6
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Lumiliximab


Catalog No. TD-HY541016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Chimeric
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target Lymphocyte IgE receptor, C-type lectin domain family 4 member J, Low affinity immunoglobulin epsilon Fc receptor, CD23A, BLAST-2, Immunoglobulin E-binding factor, IGEBF, CD23, Fc-epsilon-RII, CLEC4J, FCE2, FCER2
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P06734
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names IDEC-152,P5E8,CAS:357613-86-6
Background Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY541016_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Lumiliximab.